معرفی
Wilson Wu serves as a Research Fellow in Biochemistry & Molecular Biology at Monash University's Victorian Heart Institute (VHI). His work centers on metabolic diseases, with emphasis on type 2 diabetes and obesity, exploring liver metabolism and glucagon signaling pathways.
Research interests span metabolism, diabetes, molecular biology, and endocrinology. Key areas include glucagon pharmacotherapies, amino acid metabolism in the liver, and mechanisms of glucagon resistance. His investigations aim to uncover novel therapeutic targets for diabetes management using advanced techniques like phosphoproteomics and mouse models.
Analysis of recent publications (2021-2024) reveals a consistent focus on glucagon's metabolic actions, particularly how liver signaling nodes regulate systemic glucose homeostasis and muscle metabolism in diabetes contexts. His work integrates molecular biology with translational approaches to address metabolic dysregulation.
Dr. Wu has secured research funding as Primary Chief Investigator for a completed project (2021) on glucagon resistance mechanisms and currently serves as Associate Investigator on an active project (2025-2026) exploring liver amino acid metabolism in diabetes therapies. He collaborates extensively within the Victorian Heart Institute and with international partners including Professor Rose, A.
حوزههای پژوهشی
